Fast-forward an undisclosed number of years and Jason Surface has, according to his website, more than 2.5 million safe ...

We updated this article in April 2022 to add more information about each featured product, based on extensive research done by our team (and that of our sister team at the Good Housekeeping Institute) ...

Biogen has revealed encouraging phase 2 results with its anti-CD38 antibody felzartamab in rare kidney disease IgA nephropathy (IgAN), which it hopes could join a series of first-in-class therapies ...